Superior infectivity of the fiber chimeric oncolytic adenoviruses Ad5/35 and Ad5/3 over Ad5-delta-24-RGD in primary glioma cultures.

Autor: Stepanenko AA; Department of Fundamental and Applied Neurobiology, V.P. Serbsky National Medical Research Center of Psychiatry and Narcology, The Ministry of Health of the Russian Federation, Kropotkinsky Lane 23, 119034 Moscow, Russia.; Department of Medical Nanobiotechnology, Institute of Translational Medicine, N.I. Pirogov Russian National Research Medical University, The Ministry of Health of the Russian Federation, Ostrovitianov Str. 1, 117997 Moscow, Russia., Sosnovtseva AO; Department of Fundamental and Applied Neurobiology, V.P. Serbsky National Medical Research Center of Psychiatry and Narcology, The Ministry of Health of the Russian Federation, Kropotkinsky Lane 23, 119034 Moscow, Russia., Valikhov MP; Department of Fundamental and Applied Neurobiology, V.P. Serbsky National Medical Research Center of Psychiatry and Narcology, The Ministry of Health of the Russian Federation, Kropotkinsky Lane 23, 119034 Moscow, Russia.; Department of Medical Nanobiotechnology, Institute of Translational Medicine, N.I. Pirogov Russian National Research Medical University, The Ministry of Health of the Russian Federation, Ostrovitianov Str. 1, 117997 Moscow, Russia., Chernysheva AA; Department of Fundamental and Applied Neurobiology, V.P. Serbsky National Medical Research Center of Psychiatry and Narcology, The Ministry of Health of the Russian Federation, Kropotkinsky Lane 23, 119034 Moscow, Russia., Cherepanov SA; Department of Fundamental and Applied Neurobiology, V.P. Serbsky National Medical Research Center of Psychiatry and Narcology, The Ministry of Health of the Russian Federation, Kropotkinsky Lane 23, 119034 Moscow, Russia., Yusubalieva GM; Federal Research and Clinical Center for Specialized Types of Medical Care and Medical Technologies of the FMBA of Russia, Moscow, Russia., Ruzsics Z; Institute of Virology, Medical Center, University of Freiburg, Freiburg, Germany.; Faculty of Medicine, University of Freiburg, Freiburg, Germany., Lipatova AV; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia., Chekhonin VP; Department of Fundamental and Applied Neurobiology, V.P. Serbsky National Medical Research Center of Psychiatry and Narcology, The Ministry of Health of the Russian Federation, Kropotkinsky Lane 23, 119034 Moscow, Russia.; Department of Medical Nanobiotechnology, Institute of Translational Medicine, N.I. Pirogov Russian National Research Medical University, The Ministry of Health of the Russian Federation, Ostrovitianov Str. 1, 117997 Moscow, Russia.

Publikováno v: Molecular therapy oncolytics [Mol Ther Oncolytics] 2021 Dec 21; Vol. 24, pp. 230-248. Date of Electronic Publication: 2021 Dec 21 (Print Publication: 2022).

Multimodal doxorubicin loaded magnetic nanoparticles for VEGF targeted theranostics of breast cancer.

Autor: Semkina AS; Pirogov Russian National Research Medical University, Moscow, Russian Federation; The National University of Science and Technology MISiS, Moscow, Russian Federation., Abakumov MA; Pirogov Russian National Research Medical University, Moscow, Russian Federation; The National University of Science and Technology MISiS, Moscow, Russian Federation. Electronic address: abakumov1988@gmail.com., Skorikov AS; Lomonosov Moscow State University, Moscow, Russian Federation., Abakumova TO; Skolkovo Institute of Science and Technology, Moscow, Russian Federation., Melnikov PA; Serbsky National Medical Research Center for Psychiatry and Narcology, Moscow, Russian Federation., Grinenko NF; Serbsky National Medical Research Center for Psychiatry and Narcology, Moscow, Russian Federation., Cherepanov SA; Pirogov Russian National Research Medical University, Moscow, Russian Federation; Serbsky National Medical Research Center for Psychiatry and Narcology, Moscow, Russian Federation., Vishnevskiy DA; Pirogov Russian National Research Medical University, Moscow, Russian Federation., Naumenko VA; The National University of Science and Technology MISiS, Moscow, Russian Federation., Ionova KP; Serbsky National Medical Research Center for Psychiatry and Narcology, Moscow, Russian Federation., Majouga AG; The National University of Science and Technology MISiS, Moscow, Russian Federation; Lomonosov Moscow State University, Moscow, Russian Federation; Dmitry Mendeleev University of Chemical Technology of Russia, Moscow, Russian Federation., Chekhonin VP; Pirogov Russian National Research Medical University, Moscow, Russian Federation; Serbsky National Medical Research Center for Psychiatry and Narcology, Moscow, Russian Federation.

Publikováno v: Nanomedicine : nanotechnology, biology, and medicine [Nanomedicine] 2018 Jul; Vol. 14 (5), pp. 1733-1742. Date of Electronic Publication: 2018 May 03.

Internalization of Vectorized Liposomes Loaded with Plasmid DNA in C6 Glioma Cells.

Autor: Mel'nikov PA; Department of Fundamental and Applied Neurobiology, V. P. Serbsky Federal Medical Research Center for Psychiatry and Narcology, Ministry of Health of the Russian Federation, Moscow, Russia. proximopm@gmail.com.; Federal Clinical Research Centre, Federal Medical-Biological Agency, Moscow, Russia. proximopm@gmail.com., Baklaushev VP; Federal Clinical Research Centre, Federal Medical-Biological Agency, Moscow, Russia., Gabashvili AN; Department of Fundamental and Applied Neurobiology, V. P. Serbsky Federal Medical Research Center for Psychiatry and Narcology, Ministry of Health of the Russian Federation, Moscow, Russia., Nukolova NV; Department of Fundamental and Applied Neurobiology, V. P. Serbsky Federal Medical Research Center for Psychiatry and Narcology, Ministry of Health of the Russian Federation, Moscow, Russia.; Department of Medical Nanobiotechnologies, Medico-Biological Faculty, N. I. Pirogov National Research Medical University, Moscow, Russia., Kuznetsov II; Department of Chemical Enzymology, Faculty of Biology, M. V. Lomonosov Moscow State University, Moscow, Russia., Cherepanov SA; Department of Fundamental and Applied Neurobiology, V. P. Serbsky Federal Medical Research Center for Psychiatry and Narcology, Ministry of Health of the Russian Federation, Moscow, Russia., Koshkin FA; Department of Fundamental and Applied Neurobiology, V. P. Serbsky Federal Medical Research Center for Psychiatry and Narcology, Ministry of Health of the Russian Federation, Moscow, Russia., Leopol'd AV; Department of Fundamental and Applied Neurobiology, V. P. Serbsky Federal Medical Research Center for Psychiatry and Narcology, Ministry of Health of the Russian Federation, Moscow, Russia., Chekhonin VP; Department of Fundamental and Applied Neurobiology, V. P. Serbsky Federal Medical Research Center for Psychiatry and Narcology, Ministry of Health of the Russian Federation, Moscow, Russia.; Department of Medical Nanobiotechnologies, Medico-Biological Faculty, N. I. Pirogov National Research Medical University, Moscow, Russia.

Publikováno v: Bulletin of experimental biology and medicine [Bull Exp Biol Med] 2017 May; Vol. 163 (1), pp. 114-122. Date of Electronic Publication: 2017 Jun 03.

Pulsed Dendritic Cells for the Therapy of Experimental Glioma.

Autor: Chekhonin IV; V. P. Serbsky Federal Medical Research Centre of Psychiatry and Narcology, Ministry of Health of the Russian Federation, Moscow, Russia. ivan-chekhonin@yandex.ru., Gurina OI; V. P. Serbsky Federal Medical Research Centre of Psychiatry and Narcology, Ministry of Health of the Russian Federation, Moscow, Russia., Cherepanov SA; Department of Medical Nanobiotechnologies, Medical Biological Faculty, N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia., Abakumov MA; Department of Medical Nanobiotechnologies, Medical Biological Faculty, N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia., Ionova KP; V. P. Serbsky Federal Medical Research Centre of Psychiatry and Narcology, Ministry of Health of the Russian Federation, Moscow, Russia., Zhigarev DK; V. P. Serbsky Federal Medical Research Centre of Psychiatry and Narcology, Ministry of Health of the Russian Federation, Moscow, Russia., Makarov AV; V. P. Serbsky Federal Medical Research Centre of Psychiatry and Narcology, Ministry of Health of the Russian Federation, Moscow, Russia., Chekhonin VP; V. P. Serbsky Federal Medical Research Centre of Psychiatry and Narcology, Ministry of Health of the Russian Federation, Moscow, Russia.; Department of Medical Nanobiotechnologies, Medical Biological Faculty, N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia.

Publikováno v: Bulletin of experimental biology and medicine [Bull Exp Biol Med] 2016 Oct; Vol. 161 (6), pp. 792-796. Date of Electronic Publication: 2016 Oct 26.

Antitumor Activity of Rat Mesenchymal Stem Cells during Direct or Indirect Co-Culturing with C6 Glioma Cells.

Autor: Gabashvili AN; Department of Medical Nanobiotechnologies, Medico-Biological Faculty, N. I. Pirogov National Research Medical University, Moscow, Russia. gabashvili.anna@gmail.com., Baklaushev VP; Department of Medical Nanobiotechnologies, Medico-Biological Faculty, N. I. Pirogov National Research Medical University, Moscow, Russia.; Federal Research-and-Clinical Center, Federal Medico-Biological Agency, Moscow, Russia., Grinenko NF; Department of Fundamental and Applied Neurobiology, V. P. Serbsky Federal Medical Research Center of Psychiatry and Narcology, Ministry of Health of the Russian Federation, Moscow, Russia., Mel'nikov PA; Department of Medical Nanobiotechnologies, Medico-Biological Faculty, N. I. Pirogov National Research Medical University, Moscow, Russia., Cherepanov SA; Department of Medical Nanobiotechnologies, Medico-Biological Faculty, N. I. Pirogov National Research Medical University, Moscow, Russia., Levinsky AB; Department of Medical Nanobiotechnologies, Medico-Biological Faculty, N. I. Pirogov National Research Medical University, Moscow, Russia., Chehonin VP; Department of Medical Nanobiotechnologies, Medico-Biological Faculty, N. I. Pirogov National Research Medical University, Moscow, Russia.; Department of Fundamental and Applied Neurobiology, V. P. Serbsky Federal Medical Research Center of Psychiatry and Narcology, Ministry of Health of the Russian Federation, Moscow, Russia.

Publikováno v: Bulletin of experimental biology and medicine [Bull Exp Biol Med] 2016 Feb; Vol. 160 (4), pp. 519-24. Date of Electronic Publication: 2016 Feb 23.